1. Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?
   Lorella Vecchio et al, 2013, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
   Hamid Ali Nagi Al-Jamal et al, 2015, BMC Cancer CrossRef
3. Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells
   Lanzhu Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
4. Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis
   Sahra Borges et al, 2013, Breast Cancer Research CrossRef
5. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents
   Bryan Oronsky et al, 2016, Biomolecules CrossRef
6. DNA Demethylation Switches Oncogenic ΔNp63 to Tumor Suppressive TAp63 in Squamous Cell Carcinoma
   Zuzana Pokorna et al, 2022, Frontiers in Oncology CrossRef
7. Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy
   Guancui Yang et al, 2022, Frontiers in Immunology CrossRef
8. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
   Shi-Yong Li et al, 2015, Journal of Controlled Release CrossRef
9. Changes in the physicochemical properties of fish cell membranes during cellular senescence
   Akifumi Shiomi et al, 2020, Bioscience, Biotechnology, and Biochemistry CrossRef
10. Canonical and new generation anticancer drugs also target energy metabolism
    Sara Rodríguez-Enríquez et al, 2014, Archives of Toxicology CrossRef
11. Role of reactive oxygen species in myelodysplastic syndromes
    Qiangan Jing et al, 2024, Cellular & Molecular Biology Letters CrossRef
12. Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation
    Xiuzhen Tong et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
13. EVI1 promotes metastasis by downregulating TIMP2 in metastatic colon and breast cancer cells
    null Pradeepa et al, 2022, The International Journal of Biochemistry & Cell Biology CrossRef
14. Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways
    Jessica Dittmann et al, 2020, Cell Death & Differentiation CrossRef
15. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways
    HANA OH et al, 2016, International Journal of Oncology CrossRef
16. Decitabine promotes apoptosis in mesenchymal stromal cells isolated from patients with myelodysplastic syndromes by inducing reactive oxygen species generation
    Lihua Wang et al, 2019, European Journal of Pharmacology CrossRef
17. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine
    Siew Ching Ngai et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
18. Synergistic Effect of Epigenetic Inhibitors Decitabine and Suberoylanilide Hydroxamic Acid on Colorectal Cancer In vitro
    Sonia Abou Najem et al, 2019, Current Molecular Pharmacology CrossRef
19. 5-aza-2′-deoxycytidine promotes migration of acute monocytic leukemia cells via activation of CCL2-CCR2-ERK signaling pathway
    Xia Xiao et al, 2017, Molecular Medicine Reports CrossRef
20. Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
    Stephan R. Bohl et al, 2018, Expert Review of Hematology CrossRef
21. Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
    Verona Buocikova et al, 2022, Biomedicine & Pharmacotherapy CrossRef
22. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression
    Jing-Ting Chiou et al, 2024, Apoptosis CrossRef
23. Decitabine Induces Delayed Reactive Oxygen Species (ROS) Accumulation in Leukemia Cells and Induces the Expression of ROS Generating Enzymes
    Tamer E. Fandy et al, 2014, Clinical Cancer Research CrossRef
24. Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
    Julia Jabs et al, 2017, Molecular Systems Biology CrossRef
25. Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
    Hyunsung Park et al, 2017, Yonsei Medical Journal CrossRef
26. Synergistic inhibitory effects of low‑dose decitabine in combination with bortezomib in the AML cell line Kasumi‑1
    Vassiliki Mpakou et al, 2021, Experimental and Therapeutic Medicine CrossRef